Omeros reported $8.84M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Adma Biologics USD 24.02M 5.75M Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
Dynavax Technologies USD 3.95M 1.25M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Immunic USD 7.92M 25K Sep/2025
Insmed USD 79.59M 1.24M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 17.69M 12.44M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Rockwell Medical USD 1.5M 423K Jun/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
United Therapeutics USD 468M 36M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025
Xoma USD 2.65M 1.52M Sep/2025